Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.
about
Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.Primary in vitro cytotoxic T cell response to non-major histocompatibility complex alloantigens in normal mice.Two distinct mechanisms regulate the in vivo generation of cytotoxic T cells.Cytotoxic T lymphocyte responses in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of Ia-restricted T cells but not H-2K/D-restricted T cellsSuppressive mechanisms in alloantigen-induced T cell responses.Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania majorDown-regulation of cytotoxic T lymphocyte generation by two distinct suppressor-cell systems.Immune-interferon (IFN-gamma), macrophage-activating factors (MAFs), and colony-stimulating factors (CSFs) secreted by T cell clones in limiting dilution microcultures, long-term cultures, and by T cell hybridomas.Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins.Interleukin 2 induction in Lyt 1+ 23- T cells from Listeria monocytogenes-immune mice.Dual inhibitory and stimulatory activities in serum from SLE patients and lupus mice that regulate the proliferation of an IL-2-dependent T cell line.Suppression of interleukin 2 activity by natural products: effects of serum lipoproteins.Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesisSensitive Sandwich Enzyme Immunoassay of Human Interleukin-2 ProducedIn Vitroby Peripheral Blood Mononuclear Cells
P2860
Q36028954-E9DAB337-1DD9-40D8-8270-63705C996881Q36346369-AE2AF9CF-7E29-4E55-BA3D-D7B2E53D1BBEQ36346786-2E0EB82B-07CD-42CB-A74B-96A1BF6AF8CFQ36346885-DB1F4809-0643-4FD4-94F2-80D47B3E2B98Q36347155-8EF8E147-DBF6-4A7E-AF25-69F636A78A0EQ36348268-20926912-5A62-4962-8208-3E6D860267DCQ37010499-28A5EB74-68CD-44C8-BC85-B823855C6999Q37013127-E13BD250-9CE3-4344-A8F0-CECD4484092DQ38518755-1E0C8CBC-D290-4B7E-B928-AED51842AF64Q40210477-2C0842FB-301D-4B8F-9D64-8B650F0950DCQ40264396-DB9F77F0-A863-4D6C-827C-CA2AC20B5D4AQ40598646-06507D7B-F2E6-45AF-9D5A-86096224A85DQ41315425-87490875-C4AD-4291-9356-04782C3C06D9Q41323977-75BEB17C-D66D-4174-9C30-91A0B63F6186Q57232971-CA037D0C-7190-46F8-98BA-F1E8A6C78F90Q58129587-693E23D5-AF20-47A6-A9AB-FE24680F4E85
P2860
Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Lyt-23+ cyclophosphamide-sensi ...... terleukin 2 inhibitor in vivo.
@en
Lyt-23+ cyclophosphamide-sensi ...... terleukin 2 inhibitor in vivo.
@nl
type
label
Lyt-23+ cyclophosphamide-sensi ...... terleukin 2 inhibitor in vivo.
@en
Lyt-23+ cyclophosphamide-sensi ...... terleukin 2 inhibitor in vivo.
@nl
prefLabel
Lyt-23+ cyclophosphamide-sensi ...... terleukin 2 inhibitor in vivo.
@en
Lyt-23+ cyclophosphamide-sensi ...... terleukin 2 inhibitor in vivo.
@nl
P2093
P2860
P356
P1476
Lyt-23+ cyclophosphamide-sensi ...... terleukin 2 inhibitor in vivo.
@en
P2093
Pfizenmaier K
Röllinghoff M
P2860
P304
P356
10.1084/JEM.154.2.262
P407
P577
1981-08-01T00:00:00Z